PE20061097A1 - Compuestos de benzoxazin-2-ona con actividad betamimetica - Google Patents
Compuestos de benzoxazin-2-ona con actividad betamimeticaInfo
- Publication number
- PE20061097A1 PE20061097A1 PE2006000215A PE2006000215A PE20061097A1 PE 20061097 A1 PE20061097 A1 PE 20061097A1 PE 2006000215 A PE2006000215 A PE 2006000215A PE 2006000215 A PE2006000215 A PE 2006000215A PE 20061097 A1 PE20061097 A1 PE 20061097A1
- Authority
- PE
- Peru
- Prior art keywords
- hydroxy
- benzoxazin
- oxo
- dimethyl
- phenyl
- Prior art date
Links
- 230000003454 betamimetic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- 206010006458 Bronchitis chronic Diseases 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 208000011623 Obstructive Lung disease Diseases 0.000 abstract 1
- XIPUIGPNIDKXJU-UHFFFAOYSA-N [CH]1CC1 Chemical class [CH]1CC1 XIPUIGPNIDKXJU-UHFFFAOYSA-N 0.000 abstract 1
- 239000000808 adrenergic beta-agonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010006451 bronchitis Diseases 0.000 abstract 1
- 208000007451 chronic bronchitis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 101150008563 spir gene Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE [1,3] BENZOXAZIN-2-ONA DE FORMULA(I), EN DONDE R1 Y R2 SON INDEPENDIENTEMENTE H, HALOGENO, ALQUILO O EN FORMA CONJUNTA ALQUILENO(C1-C6); R3 ES H, HALOGENO, OH, ALQUILO(C1-C4) O ALQUILO(C1-C4)-O-. SON PREFERIDOS: N-(5-{2-[1,1-DIMETIL-3-(4-METIL-2-OXO-4H-BENZO[d][1,3]OXAZIN-1-IL)-PROPILAMINO]-1-HIDROXI-ETIL}-2-HIDROXI-FENIL)-METANOSULFONAMIDA, N-(5-{2-[1,1-DIMETIL-3-(2-OXO-4,4-DIPROPIL-4H-BENZO[d][1,3]OXAZIN-1-IL)-PROPILAMINO]-1-HIDROXI-ETIL}-2-HIDROXI-FENIL)-METANOSULFONAMIDA, N-(5-{2-[1,1-DIMETIL-3-[ESPIRO(CICLOPROPIL)-1,4'-2H-3',1'-BENZOXAZIN)-2-OXO-1-IL)-PROPILAMINO]-1-HIDROXI-ETIL}-2-HIDROXI-FENIL)-METANOSULFONAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCESO DE PREPARACION Y UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON BETAMIMETICOS ALTAMENTE SELECTIVOS RESPECTO DEL ADRENORECEPTOR ß2, POR LO QUE SON UTILES EN EL TRATAMIENTO DE ENFERMEDADES PULMONARES OBSTRUCTIVAS, TALES COMO ASMA, BRONQUITIS CRONICA, EPOC
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005008921A DE102005008921A1 (de) | 2005-02-24 | 2005-02-24 | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061097A1 true PE20061097A1 (es) | 2006-11-14 |
Family
ID=36179764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000215A PE20061097A1 (es) | 2005-02-24 | 2006-02-22 | Compuestos de benzoxazin-2-ona con actividad betamimetica |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US20060189605A1 (es) |
| EP (1) | EP1856070B1 (es) |
| JP (1) | JP4950075B2 (es) |
| KR (1) | KR20070110386A (es) |
| CN (1) | CN101128444A (es) |
| AR (1) | AR055562A1 (es) |
| AT (1) | ATE517877T1 (es) |
| AU (1) | AU2006218010B2 (es) |
| BR (1) | BRPI0607258A2 (es) |
| CA (1) | CA2598914A1 (es) |
| DE (1) | DE102005008921A1 (es) |
| DK (1) | DK1856070T3 (es) |
| EA (1) | EA012439B1 (es) |
| ES (1) | ES2370653T3 (es) |
| IL (1) | IL185444A0 (es) |
| MX (1) | MX2007010363A (es) |
| MY (1) | MY146802A (es) |
| NO (1) | NO20073176L (es) |
| NZ (1) | NZ561743A (es) |
| PE (1) | PE20061097A1 (es) |
| PL (1) | PL1856070T3 (es) |
| TW (1) | TWI369988B (es) |
| UA (1) | UA90504C2 (es) |
| UY (1) | UY29394A1 (es) |
| WO (1) | WO2006089859A1 (es) |
| ZA (1) | ZA200704727B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| US7423146B2 (en) | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| PE20081358A1 (es) * | 2006-08-22 | 2008-10-31 | Boehringer Ingelheim Int | Combinaciones farmacologicas para el tratamiento de enfermedades de la vias aereas |
| PE20080610A1 (es) | 2006-08-22 | 2008-07-15 | Boehringer Ingelheim Int | Nuevos beta-agonistas enantiomericamente puros, procedimientos para su preparacion y uso como medicamentos |
| PE20080425A1 (es) * | 2006-08-22 | 2008-06-16 | Boehringer Ingelheim Int | Formulacion aerosol para la inhalacion de beta-agonistas |
| CA2661481A1 (en) * | 2006-08-22 | 2008-02-28 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation containing enantiomerically pure beta-agonists |
| EP2093219A1 (de) * | 2008-02-22 | 2009-08-26 | Boehringer Ingelheim International Gmbh | Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel |
| GB201217330D0 (en) * | 2012-09-28 | 2012-11-14 | Univ Cardiff | Therapeutic for treating inflammatory lung disorders |
| US10421794B2 (en) * | 2014-12-24 | 2019-09-24 | Kither Biotech Srl | PI3K gamma inhibitor peptide for treatment of respiratory system diseases |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3026534A1 (de) | 1980-07-12 | 1982-03-18 | C.H. Boehringer Sohn, 6507 Ingelheim | 3,1-benzoxazin-2-one, ihre herstellung und verwendung |
| US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
| US4570630A (en) * | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
| DE3609152A1 (de) * | 1986-03-19 | 1987-09-24 | Bayer Ag | Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens |
| ATE421322T1 (de) * | 2003-04-04 | 2009-02-15 | Novartis Pharma Gmbh | Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege |
| DE102004003428A1 (de) * | 2004-01-23 | 2005-08-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| DE102005008921A1 (de) * | 2005-02-24 | 2006-08-31 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von Atemwegserkrankungen |
| US7423146B2 (en) * | 2005-11-09 | 2008-09-09 | Boehringer Ingelheim International Gmbh | Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones |
| PE20081358A1 (es) * | 2006-08-22 | 2008-10-31 | Boehringer Ingelheim Int | Combinaciones farmacologicas para el tratamiento de enfermedades de la vias aereas |
| PE20080425A1 (es) * | 2006-08-22 | 2008-06-16 | Boehringer Ingelheim Int | Formulacion aerosol para la inhalacion de beta-agonistas |
-
2005
- 2005-02-24 DE DE102005008921A patent/DE102005008921A1/de not_active Withdrawn
-
2006
- 2006-02-16 BR BRPI0607258-5A patent/BRPI0607258A2/pt not_active IP Right Cessation
- 2006-02-16 AU AU2006218010A patent/AU2006218010B2/en not_active Expired - Fee Related
- 2006-02-16 UA UAA200710494A patent/UA90504C2/ru unknown
- 2006-02-16 NZ NZ561743A patent/NZ561743A/en not_active IP Right Cessation
- 2006-02-16 AT AT06708325T patent/ATE517877T1/de active
- 2006-02-16 CA CA002598914A patent/CA2598914A1/en not_active Abandoned
- 2006-02-16 ES ES06708325T patent/ES2370653T3/es active Active
- 2006-02-16 JP JP2007556591A patent/JP4950075B2/ja active Active
- 2006-02-16 PL PL06708325T patent/PL1856070T3/pl unknown
- 2006-02-16 EP EP06708325A patent/EP1856070B1/de active Active
- 2006-02-16 WO PCT/EP2006/060033 patent/WO2006089859A1/de not_active Ceased
- 2006-02-16 EA EA200701615A patent/EA012439B1/ru not_active IP Right Cessation
- 2006-02-16 CN CNA2006800060256A patent/CN101128444A/zh active Pending
- 2006-02-16 MX MX2007010363A patent/MX2007010363A/es active IP Right Grant
- 2006-02-16 DK DK06708325.3T patent/DK1856070T3/da active
- 2006-02-16 KR KR1020077021896A patent/KR20070110386A/ko not_active Ceased
- 2006-02-22 PE PE2006000215A patent/PE20061097A1/es not_active Application Discontinuation
- 2006-02-22 MY MYPI20060756A patent/MY146802A/en unknown
- 2006-02-23 US US11/276,307 patent/US20060189605A1/en not_active Abandoned
- 2006-02-23 TW TW095106149A patent/TWI369988B/zh not_active IP Right Cessation
- 2006-02-24 AR ARP060100674A patent/AR055562A1/es unknown
- 2006-02-24 UY UY29394A patent/UY29394A1/es not_active Application Discontinuation
-
2007
- 2007-06-14 ZA ZA200704727A patent/ZA200704727B/xx unknown
- 2007-06-22 NO NO20073176A patent/NO20073176L/no not_active Application Discontinuation
- 2007-08-22 IL IL185444A patent/IL185444A0/en unknown
-
2008
- 2008-12-18 US US12/338,333 patent/US20090105236A1/en not_active Abandoned
-
2010
- 2010-11-05 US US12/940,492 patent/US20110053926A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20090105236A1 (en) | 2009-04-23 |
| EA200701615A1 (ru) | 2008-02-28 |
| TW200640465A (en) | 2006-12-01 |
| TWI369988B (en) | 2012-08-11 |
| DK1856070T3 (da) | 2011-09-26 |
| EA012439B1 (ru) | 2009-10-30 |
| NO20073176L (no) | 2007-09-17 |
| EP1856070A1 (de) | 2007-11-21 |
| CN101128444A (zh) | 2008-02-20 |
| CA2598914A1 (en) | 2006-08-31 |
| UA90504C2 (ru) | 2010-05-11 |
| NZ561743A (en) | 2009-09-25 |
| AR055562A1 (es) | 2007-08-22 |
| MY146802A (en) | 2012-09-28 |
| IL185444A0 (en) | 2008-01-06 |
| ATE517877T1 (de) | 2011-08-15 |
| DE102005008921A1 (de) | 2006-08-31 |
| US20060189605A1 (en) | 2006-08-24 |
| AU2006218010A1 (en) | 2006-08-31 |
| ZA200704727B (en) | 2008-09-25 |
| JP4950075B2 (ja) | 2012-06-13 |
| MX2007010363A (es) | 2007-09-25 |
| AU2006218010B2 (en) | 2013-02-14 |
| KR20070110386A (ko) | 2007-11-16 |
| WO2006089859A1 (de) | 2006-08-31 |
| JP2008531518A (ja) | 2008-08-14 |
| ES2370653T3 (es) | 2011-12-21 |
| EP1856070B1 (de) | 2011-07-27 |
| US20110053926A1 (en) | 2011-03-03 |
| PL1856070T3 (pl) | 2011-12-30 |
| UY29394A1 (es) | 2006-10-02 |
| BRPI0607258A2 (pt) | 2009-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29457A1 (es) | Compuestos novedosos de derivados de aminosulfonilo | |
| ZA201002690B (en) | N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors | |
| CL2007003765A1 (es) | Compuestos derivados de 2-oxo-4-hidroxi-benzotiazol; procesode preparacion; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, bronquitis, asma y bronquiectasias. | |
| EA200901241A1 (ru) | Соединения для лечения гепатита с | |
| MX2009002239A (es) | Derivados de 5-(2-furil)-1,3-tiazol util como inhibidores de fosfatidilinositol 3-cinasa. | |
| CL2012001464A1 (es) | Compuestos derivados de (2-amino-5,5-difluor-5,6-dihidro-4h-[1,3]oxazin-4-il)-fenilamida, inhibidores bace1 y/o bace2; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento terapeutico y/o profilactico de enfermedades tales como alzheimer y diabetes. | |
| DOP2006000210A (es) | Compuestos de pirimidina amida como inhibidores de pgds | |
| PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
| SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| PE20090288A1 (es) | Derivados de quinoxalina como inhibidores de la pi3 quinasa | |
| ATE482210T1 (de) | Oxadiazolderivate als s1p1-rezeptor-agonisten | |
| CL2011001082A1 (es) | Compuestos derivados de amino-tetrahidropiranos sustituidos con heterociclos, composicion farmaceutica; y uso en el tratamiento de una afeccion seleccionada de resistencia a la insulina, hiperglicemia y diabetes de tipo 2. | |
| WO2012018534A3 (en) | Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases | |
| WO2008106058A3 (en) | Inhibitors of serine proteases | |
| CL2009000860A1 (es) | Compuestos derivados de 4-fenil-4-metil-5,6-dihidro-4h-1,3-tiazina-2-amina; composiciones farmaceuticas que los contienen; y uso de los compuestos en la preparacion de medicamentos inhibidores de bace, utiles para el tratamiento de trastornos mediados por esta enzima, tal como la enfermedad de alzheimer. | |
| CO6592102A2 (es) | Compuestos de sililo triciclicos fusionados y metodos de uso de los mismos para el tratamiento de enfermedades virales | |
| TW201129565A (en) | Tricyclic heterocyclic compounds, compositions and methods of use thereof | |
| NO20084853L (no) | Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni | |
| EA201391720A1 (ru) | Замещенные диоксопиперидинилфталимидные производные | |
| CO6251282A2 (es) | Oxazolidinonas sustituidas y su uso | |
| TW200745004A (en) | Novel compounds, their preparation and use | |
| CL2008002689A1 (es) | Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia. | |
| PE20070362A1 (es) | COMPUESTOS DERIVADOS DE INDAZOL-4-IL-2,4-PIRIMIDINDIAMINA COMO INHIBIDORES DE TIROSINA QUINASA (QUINASA Syk) | |
| WO2009085271A3 (en) | Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions | |
| PE20061097A1 (es) | Compuestos de benzoxazin-2-ona con actividad betamimetica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |